Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Regarding the aggressiveness of the tumor, only 14% of the prostate cancers studied were high risk (Gleason score ≥8), compared to 45% that were low grade (Gleason ≤6).Characteristics of the MCC-Spain study participants.CharacteristicControlCaseCrude OR95% CIn%n% Age <65 years41040.7634241.811.00 ≥65 years59659.2447658.190.950.79 to 1.15 Family History of PCa No93092.7264979.731.00 Yes 73 7.28 165 20.27 3.29 2.44 to 4.43 Diabetes No78377.9968884.421.00 Yes, without pharmacological treatment 37 3.69 14 1.72 0.41 0.22 to 0.77 Yes, with oral antidiabetic treatment 143 14.24 86 10.55 0.69 0.52 to 0.92 Yes, treated with insulin252.49121.470.580.29 to 1.18 Yes, both treatments (oral + insulin)161.59151.841.020.50 to 2.08 Hypertension No49849.6544854.971.00 Yes, without pharmacological treatment383.79273.310.790.47 to 1.32 Yes, with pharmacological treatment 467 46.56 340 41.72 0.80 0.66 to 0.96 Smoking Non-smoker27527.3424029.341.00 Former/Current smoker73172.6657870.660.910.74 to 1.13 Alcohol Tertile 131035.7121730.521.00 Tertile 2 274 31.57 253 35.58 1.29 1.01 to 1.65 Tertile 328432.7224133.901.170.91 to 1.50 Spirits (g/d) Tertile 153459.8744961.421.00 Tertile 217519.6212016.420.820.63 to 1.07 Tertile 318320.5216222.161.010.79 to 1.30 Body Mass Index one year before Normal (18.5 to 24.9 kg/m2)24023.8621025.671.00 Overweight (25.0 to 29.9 kg/m2),52852.4942451.830.900.72 to 1.13 Obese (≥30 kg/m2)23523.3618222.250.830.63 to 1.09 Weight Tertile 133233.3328334.721.00 Tertile 233233.3329135.710.990.79 to 1.24 Tertile 333233.3324129.570.850.67 to 1.07 Waist circumference Tertile 136236.4927737.481.00 Tertile 232232.4624733.421.000.79 to 1.26 Tertile 330831.0521529.090.910.71 to 1.15 Physical Activity in Leisure Time Moderate/vigorous (≥6 METs)61160.7451963.451.00 Light (<3 METs)39539.2629936.550.900.74 to 1.10 Vegetables >200 g/day25729.6122631.791.00 ≤200 g/day61170.3948568.210.910.73 to 1.13 Fruits >200 g/day61170.3951973.001.00 ≤200 g/day25729.6119227.000.840.67 to 1.05 Fish Tertile 329032.5125134.341.00 Tertile 229633.1824233.110.950.75 to 1.21 Tertile 130634.3023832.560.900.71 to 1.15 Red Meat ≤65 g/day44050.6930943.461.00 >65 g/day42849.3140256.54 1.35 1.10 to 1.65 Milk Tertile 133637.6728138.441.00 Tertile 224927.9121929.961.080.85 to 1.38 Tertile 330734.4223131.600.970.77 to 1.23 Dairy foods* Tertile 129332.8524833.931.00 Tertile 230233.8624132.970.960.75 to 1.22 Tertile 329733.3024233.111.040.81 to 1.32 Dietary calcium (mg/d) Tertile 129332.8524833.931.00 Tertile 230434.0823732.420.940.74 to 1.20 Tertile 329533.0724633.651.040.81 to 1.32 Dietary vitamin D Tertile 129332.8524833.931.00 Tertile 229533.0724633.650.990.78 to 1.26 Tertile 330434.0823732.420.960.73 to 1.18*Dairy foods include milk, yogurt and cheese.Associations with P < 0.05 are shown in bold.

Source: Population description and modifiable risk factor score. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The Multi Case-Control (MCC-Spain) study is a population based case-control study of common tumors in Spain and has been described elsewhere.

Source: Methods.

Among these cases and controls, there were only two Arabic individuals (one case and one control); the rest of the participants were White/Caucasian.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study

Case-control study · Scientific Reports · 2017

Original publication title

Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study

Inés Gómez-Acebo; Trinidad Dierssen-Sotos; Pablo Fernandez-Navarro; Camilo Palazuelos; Víctor Moreno; Nuria Aragonés; Gemma Castaño-Vinyals; Jose J. Jiménez-Monleón; Jose Luis Ruiz-Cerdá; Beatriz Pérez-Gómez; José Manuel Ruiz-Dominguez; Jessica Alonso Molero; Marina Pollán; Manolis Kogevinas; Javier Llorca

© The Author(s) 2017

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score.

In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74).

Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.

Authors’ abstract

Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score.

In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74).

Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.

Publication and source details

Original title: Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study

Inés Gómez-Acebo; Trinidad Dierssen-Sotos; Pablo Fernandez-Navarro; Camilo Palazuelos; Víctor Moreno; Nuria Aragonés; Gemma Castaño-Vinyals; Jose J. Jiménez-Monleón; Jose Luis Ruiz-Cerdá; Beatriz Pérez-Gómez; José Manuel Ruiz-Dominguez; Jessica Alonso Molero; Marina Pollán; Manolis Kogevinas; Javier Llorca

Scientific Reports · 2017

© The Author(s) 2017https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:32:06.826831+00:00

DOI: 10.1038/s41598-017-09386-9 · PMC5566549